Clinical Trials in Hong Kong, Hong Kong
55 recruiting
Showing 1–20 of 48 trials
Recruiting
Phase 3
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Acute Coronary Syndrome
Novartis Pharmaceuticals300 enrolled58 locationsNCT07102628
Recruiting
Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level
Tuberculosis
Chinese University of Hong Kong85 enrolled2 locationsNCT07170735
Recruiting
Not Applicable
Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild Cognitive Impairment
Cognitive Functions
City University of Hong Kong110 enrolled1 locationNCT07372066
Recruiting
Phase 1Phase 2
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
LGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell LymphomaPrimary Cutaneous CD8+ Aggressive Epidermotropic T-Cell Lymphoma+2 more
Dren Bio200 enrolled37 locationsNCT05475925
Recruiting
Phase 2
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Novartis Pharmaceuticals240 enrolled103 locationsNCT05268289
Recruiting
Not Applicable
Evaluating the Effectiveness of Interventions to Reduce Loneliness in Hong Kong Younger Adults
Loneliness
Education University of Hong Kong110 enrolled1 locationNCT07543653
Recruiting
Phase 3
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals340 enrolled92 locationsNCT06813911
Recruiting
Phase 3
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerER Positive Breast Cancer+1 more
Olema Pharmaceuticals, Inc.1,000 enrolled85 locationsNCT07085767
Recruiting
Not Applicable
Enhancing Physical Reserve to Promote Resilience in Physically Frail Older Adults
Frailty at Older Adults
The Hong Kong Polytechnic University224 enrolled1 locationNCT07513701
Recruiting
Not Applicable
rTMS Treatment of Spasticity in Children With Cerebral Palsy/ Hemiplegia Due to ABI - a RCT
CP (Cerebral Palsy)
The University of Hong Kong20 enrolled1 locationNCT06128746
Recruiting
Not Applicable
Adjunctive Bright Light Therapy in Adolescents With Depression and Eveningness
Depression, Unipolar
Chinese University of Hong Kong90 enrolled1 locationNCT06973759
Recruiting
Developing a Methodological Framework and a Dissemination Plan for Herb-drug Interactions-related Clinical Practice Guidelines
Herb-drug Interactions
Chinese University of Hong Kong40 enrolled1 locationNCT07248826
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Not Applicable
Digital-supported Orofacial Myofunctional Therapy in OSA
Obstructive Sleep Apnea (OSA)
Hong Kong Metropolitan University60 enrolled1 locationNCT07292922
Recruiting
Not Applicable
An Oncology Nurse AI Agent to Reduce Cancer Distress During Radiotherapy
Head and Neck Cancer
The University of Hong Kong138 enrolled2 locationsNCT06636188
Recruiting
Not Applicable
Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control
Intracerebral Hemorrhage
The University of Hong Kong140 enrolled4 locationsNCT07458880
Recruiting
Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
Primary IgA Nephropathy
Novartis Pharmaceuticals540 enrolled161 locationsNCT04557462
Recruiting
Phase 2Phase 3
Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)
Chinese University of Hong Kong30 enrolled2 locationsNCT05766124
Recruiting
Not Applicable
Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension
Hypertension
Chinese University of Hong Kong364 enrolled1 locationNCT06524180
Recruiting
Phase 4
Effect of JAK Inhibitor on Erosion Healing in RA
Rheumatoid Arthritis
Chinese University of Hong Kong60 enrolled1 locationNCT05955066